AMEDEI, AMEDEO
 Distribuzione geografica
Continente #
NA - Nord America 15.390
EU - Europa 12.262
AS - Asia 9.009
SA - Sud America 1.231
AF - Africa 212
OC - Oceania 156
Continente sconosciuto - Info sul continente non disponibili 3
Totale 38.263
Nazione #
US - Stati Uniti d'America 15.225
RU - Federazione Russa 4.248
PL - Polonia 3.125
SG - Singapore 2.626
CN - Cina 2.321
HK - Hong Kong 1.635
IT - Italia 1.562
BR - Brasile 1.006
KR - Corea 943
IE - Irlanda 937
SE - Svezia 678
FI - Finlandia 450
VN - Vietnam 448
DE - Germania 342
IN - India 317
GB - Regno Unito 221
ID - Indonesia 204
UA - Ucraina 177
FR - Francia 171
AU - Australia 152
JO - Giordania 143
NL - Olanda 115
CA - Canada 83
AR - Argentina 77
ES - Italia 58
TR - Turchia 57
EC - Ecuador 51
MX - Messico 50
JP - Giappone 46
CI - Costa d'Avorio 44
ZA - Sudafrica 44
BD - Bangladesh 40
IQ - Iraq 40
CH - Svizzera 39
CO - Colombia 26
IR - Iran 26
AT - Austria 24
BE - Belgio 23
EG - Egitto 22
MA - Marocco 22
BJ - Benin 19
CZ - Repubblica Ceca 19
PK - Pakistan 18
PY - Paraguay 18
CL - Cile 17
SA - Arabia Saudita 17
IL - Israele 15
UZ - Uzbekistan 15
LT - Lituania 14
VE - Venezuela 14
PE - Perù 13
DZ - Algeria 12
KZ - Kazakistan 12
RO - Romania 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
KE - Kenya 9
NP - Nepal 9
DO - Repubblica Dominicana 8
TW - Taiwan 8
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
OM - Oman 7
SC - Seychelles 7
UY - Uruguay 7
MY - Malesia 6
PH - Filippine 6
PT - Portogallo 6
TH - Thailandia 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
UG - Uganda 5
BY - Bielorussia 4
DK - Danimarca 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
RS - Serbia 4
BH - Bahrain 3
EE - Estonia 3
EU - Europa 3
GR - Grecia 3
NO - Norvegia 3
YT - Mayotte 3
BB - Barbados 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LV - Lettonia 2
ML - Mali 2
MN - Mongolia 2
NG - Nigeria 2
Totale 38.240
Città #
Santa Clara 3.527
Warsaw 3.119
Singapore 1.888
Ashburn 1.713
Fairfield 1.296
Hong Kong 1.226
Dublin 928
Seoul 926
Hefei 850
Chandler 701
Woodbridge 565
Seattle 557
Cambridge 517
Houston 507
Wilmington 416
Beijing 412
Florence 367
Altamura 314
Lawrence 309
San Jose 302
Jacksonville 253
Ann Arbor 243
Los Angeles 228
Princeton 224
Helsinki 216
Buffalo 212
Moscow 181
Mumbai 166
Boston 157
Jakarta 157
Munich 146
Dallas 144
Melbourne 141
New York 135
Ho Chi Minh City 126
Kent 120
Boardman 100
Paris 89
Dong Ket 86
Shanghai 84
Chicago 83
Medford 83
São Paulo 83
San Diego 81
The Dalles 81
Lappeenranta 75
Hanoi 67
Milan 58
Clifton 56
London 55
Rome 54
Abidjan 44
Bengaluru 42
Tokyo 42
Redondo Beach 41
Turku 41
Phoenix 39
Pune 39
Falls Church 36
Toronto 35
Hillsboro 33
Council Bluffs 30
Guangzhou 30
Salt Lake City 28
West Jordan 28
Brooklyn 27
Yubileyny 26
Frankfurt am Main 25
Bern 22
Bologna 22
Guayaquil 22
Haiphong 22
Rio de Janeiro 22
Amman 21
Atlanta 21
Brussels 21
Norwalk 21
Vienna 20
Baghdad 19
Belo Horizonte 19
Chennai 19
Cotonou 19
Curitiba 19
Elk Grove Village 19
Johannesburg 19
Redwood City 19
Fiesole 18
Izmir 18
Andover 17
Denver 17
Stockholm 17
Brasília 16
Tianjin 16
Guarulhos 15
Orem 15
Biên Hòa 14
Quito 14
Salerno 14
San Francisco 14
Amsterdam 13
Totale 25.594
Nome #
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 381
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 358
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 336
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 317
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 306
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 297
Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration 292
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 281
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 269
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 266
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 257
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 255
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 249
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 248
T cells in gastric cancer: friends or foes. 245
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 241
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 237
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 236
Healthy axis: Towards an integrated view of the gut-brain health 234
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 234
Evaluation and comparison of short chain fatty acids composition in gut diseases 227
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 226
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 219
I’ve gut a feeling: Microbiota impacting the conceptual and experimental perspectives of personalized medicine 214
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 213
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 212
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. 210
Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine 207
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 204
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 203
Preliminary Analysis of the Presence of Bacterial Azurin Coding Gene in CRC Patients and Correlation with the Microbiota Composition 198
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 198
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 197
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 196
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 196
Thrombosis in vasculitis: from pathogenesis to treatment 194
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 192
Effect of probiotics on oral candidiasis: A systematic review and meta-analysis 190
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 188
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 187
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 186
Editorial of special issue “the interplay of microbiome and immune response in health and diseases” 185
The lung microbiome: clinical and therapeutic implications 185
Broad targeting of angiogenesis for cancer prevention and therapy 184
Gastric cancer and the epoch of immunotherapy approaches 183
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test 183
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 181
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 181
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 178
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 176
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 175
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 175
The controversial role of Enterococcus faecalis in colorectal cancer 174
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 173
Role of Gut Microbiota-Immunity Axis in Patients Undergoing Surgery for Colorectal Cancer: Focus on Short and Long-Term Outcomes 173
Circulating Calprotectin (cCLP) in autoimmune diseases 171
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 171
Circadian rhythms, gut microbiota, and diet: possible implications for health 170
Designing a broad-spectrum integrative approach for cancer prevention and treatment 170
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 168
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. 167
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 166
Broad targeting of resistance to apoptosis in cancer 166
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 164
Effect of ancient wheat pasta on gut microbiota composition and bacteria-derived metabolites: A randomized controlled trial 163
The interplay between the microbiome and the adaptive immune response in cancer development 163
Gut inflammatory diseases, infection, and nutrition 163
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 163
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 163
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 162
Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic 161
Gut microbiota and artificial intelligence approaches: A scoping review 161
Exploring the food-gut axis in immunotherapy response of cancer patients 160
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 160
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy 159
Z-crystallin is a new stabilizing bcl-2 mRNA au-rich element binding protein overexpressed in the acute lymphocytic leukemia Jurkat T-CELL line 159
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine 158
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 158
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 158
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 157
Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients 157
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 156
A multi-targeted approach to suppress tumor-promoting inflammation 155
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. 155
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 154
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 154
SUBJECT-SPECIFIC DIRICHLET-MULTINOMIAL REGRESSION FOR MULTI-DISTRICT MICROBIOTA DATA ANALYSIS 152
Vaginal lactobacilli and vaginal dysbiosis-associated bacteria differently affect cervical epithelial and immune homeostasis and anti-viral defenses 151
JAK inhibitors and autoimmune rheumatic diseases. 150
Hydrogen sulfide effects on the survival of lactobacilli with emphasis on the development of inflammatory bowel diseases 150
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 149
Circulating miRNome profiling data in Behçet's syndrome 149
Role of diet and gut microbiota on Colorectal cancer immunomodulation 148
Effectiveness of a Khorasan Wheat–Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia 148
Impact of microbiota-immunity axis in pancreatic cancer management 147
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 147
Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study 146
Targeting IL-23 in human diseases. 146
Impact of acidosis on ζ-crystallin-mediated bcl-2 expression in leukemic cell lines 146
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers 146
Totale 19.389
Categoria #
all - tutte 113.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.205 0 0 0 0 0 0 133 208 198 376 111 179
2021/20221.377 36 107 138 64 40 64 48 163 62 57 187 411
2022/20234.044 360 854 172 221 246 625 510 407 365 56 144 84
2023/20241.902 62 154 287 91 125 332 70 330 44 176 108 123
2024/202512.470 409 1.306 809 1.781 3.226 1.502 357 734 620 408 594 724
2025/202610.270 1.778 2.227 1.822 1.495 1.725 693 530 0 0 0 0 0
Totale 38.872